Boswellia Serrata Extract hmoov

Tsis zoo li cov pa uas tsis yog -steroidal anti- cov tshuaj tiv thaiv kab mob (NSAIDs) uas ua haujlwm ntawm COX txoj hauv kev, Boswellia serrata extract exerts ib tug txawv anti- inflammatory txheej txheem yam tsis ua mob plab hnyuv mucosa:

Dual Anti-Inflammatory Target Inhibition

• Allosteric 5-LOX Inhibition: AKBA ncaj qha khi rau 5-lipoxygenase (5-LOX) hauv qhov tsis sib tw, allosteric yam, thaiv kev hloov pauv ntawm arachidonic acid rau hauv cov neeg kho mob pro-inflammatory leukotriene B4.
• mPGES-1 Inhibition: Nws suppresses microsomal prostaglandin E synthase-1, txo PGE_2 ntau lawm thiab alleviating localized redness, o, thiab mob.

Thaiv ntawm NF-κB txoj kev taw qhia

Qhov kev ua no inhibits cov haujlwm ntawm IκB kinase (IKK), yog li tiv thaiv kev hloov pauv ntawm NF -κB mus rau hauv lub nucleus. Qhov no downregulates cov noob qhia ntawm cov tseem ceeb pro-inflammatory cytokines (xws li TNF- , IL-1 , thiab IL-6).

Matrix Metalloproteinase (MMP) Txoj Cai

Nws txo cov kev ua ub no ntawm MMP-3, MMP-9, thiab MMP-13, zoo thaiv cov enzymatic degradation ntawm articular pob txha mos collagen network.

Txhawm rau txhawb cov qauv- ua haujlwm thov rau cov neeg siv khoom tiav, cov tswv lag luam xav tau cov ntaub ntawv kho mob tib neeg:

• Osteoarthritis (OA) & Joint Mobility

Randomized ob - qhov muag tsis pom kev sim (RCTs) qhia tau tias kev noj tshuaj txhua hnub nrog siab -AKBA standardized extract (piv txwv li, 100 mg / hnub rau 5-7 hnub sib law liag) ua rau muaj kev txo qis hauv WOMAC osteoarthritis index qhab nia, nrog rau kev sib koom ua ke sai thiab txhim kho qhov mob.

• Kab mob plab hnyuv

Vim leukotriene $\\text{LTB}_4$ yog tus neeg nruab nrab tseem ceeb ntawm txoj hnyuv mucosal o, boswellic acids xaiv inhibit 5-LOX los kho cov hnyuv mucosal barrier, zoo txo ​​qhov mob plab thiab hnoos qeev cov tsos mob hauv cov neeg mob ulcerative colitis (UC).

• Respiratory & Airway Health

Los ntawm kev txo cov leukotriene-induced bronchial smooth muscle constriction thiab allergic mucus hypersecretion, nws muab kev txhawb pab rau kev ua xua hawb pob thiab mob ntsws ua pa.

Tsoos boswellic acids (tshwj xeeb tshaj yog AKBA) yog cov lipophilic compounds nrog keeb kwm txwv txoj hnyuv:

Absorption Barriers:

Unformulated qhov ncauj boswellic acids pom muaj qhov ncauj bioavailability tsawg thiab muaj ntau nyob ntawm kev noj zaub mov muaj roj rau kev nqus (siab- noj zaub mov muaj roj ntau ntxiv rau cov ntshav plasma).

Formulation Delivery Technologies :

• Phytosome Technology: Complexing boswellia extract nrog paj noob hlis lossis soy lecithin txhim kho qhov ncauj bioavailability los ntawm 3-5 zaug.
• Tus kheej -Microemulsifying Drug Delivery Systems (SMEDDS): Txhim kho cov dej solubility thiab dispersibility, ua cov khoom xyaw haum rau cov kua softgels los yog npaj tau- rau- haus (RTD) dej haus.